Related references
Note: Only part of the references are listed.Necroptosis
Andreas Linkermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
TNF-α-mediated NF-κB survival signaling impairment by cisplatiri enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells
Giulia Benedetti et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity
T. Hemmerle et al.
BRITISH JOURNAL OF CANCER (2013)
Death receptors as targets in cancer
O. Micheau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours
G. Spitaleri et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Toward Improved Understanding of the Ethical and Clinical Issues Surrounding Mandatory Research Biopsies
Jeffrey Peppercorn
JOURNAL OF CLINICAL ONCOLOGY (2013)
Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma
Francesco Papadia et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
CD95 in cancer: tool or target?
Ana Martin-Villalba et al.
TRENDS IN MOLECULAR MEDICINE (2013)
TNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway
F. Marques-Fernandez et al.
CELL DEATH & DISEASE (2013)
The Nuclear Factor κB Family Member RelB Facilitates Apoptosis of Renal Epithelial Cells Caused by Cisplatin/Tumor Necrosis Factor α Synergy by Suppressing an Epithelial to Mesenchymal Transition-Like Phenotypic Switchs
Giulia Benedetti et al.
MOLECULAR PHARMACOLOGY (2013)
Signal transduction by tumor necrosis factor receptors
Lucia Cabal-Hierro et al.
CELLULAR SIGNALLING (2012)
NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression
Feiyan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
Anneleen Decock et al.
GENOME BIOLOGY (2012)
Hypermethylation of Apoptotic Genes as independent Prognostic Factor in Neuroblastoma Disease
Elena Grau et al.
MOLECULAR CARCINOGENESIS (2011)
Crosstalk in NF-κB signaling pathways
Andrea Oeckinghaus et al.
NATURE IMMUNOLOGY (2011)
TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
H. Rauert et al.
CELL DEATH & DISEASE (2011)
Exploring death receptor pathways as selective targets in cancer therapy
Maria Russo et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Apoptosis, proliferation and NF-κB activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor
Magne Børset et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Improving TNF as a cancer therapeutic: Tailor-made TNF fusion proteins with conserved antitumor activity and reduced systemic side effects
Jeannette Gerspach et al.
BIOFACTORS (2009)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line
Yohko Nakamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Transcription factor NF-κB differentially regulates death receptor 5 expression involving histone deacetylase 1
S Shetty et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Interferon-γ induces caspase-8 in neuroblastomas without affecting methylation of caspase-8 promoter
S Kim et al.
JOURNAL OF PEDIATRIC SURGERY (2004)
The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-κB signaling
C Sole et al.
JOURNAL OF CELL BIOLOGY (2004)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma
I Petak et al.
CELL DEATH AND DIFFERENTIATION (2003)
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex
N Holler et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
NF-κB-mediated up-regulation of Bcl-XS and Bax contributes to cytochrome c release in cyanide-induced apoptosis
Y Shou et al.
JOURNAL OF NEUROCHEMISTRY (2002)
IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway
S Fulda et al.
ONCOGENE (2002)
Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB
GM Kasof et al.
ONCOGENE (2001)
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
SD Catz et al.
ONCOGENE (2001)
Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor κB sites in prostatic carcinoma
S Santourlidis et al.
MOLECULAR CARCINOGENESIS (2001)
Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death
T Teitz et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
NF-κB signals induce the expression of c-FLIP
O Micheau et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells -: Disappearance of the caspase-activated DNase
VJ Yuste et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p53 Cellular localization and function in neuroblastoma -: Evidence for defective G1 arrest despite WAF1 induction in MYCN-amplified cells
DA Tweddle et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)